| mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
| mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |